Form 4: Caveness Michelle H reports acquisition/exercise transactions in EMN

Rhea-AI Filing Summary

Caveness Michelle H reported acquisition or exercise transactions in a Form 4 filing for EMN. The filing lists transactions totaling 1,937 shares. Following the reported transactions, holdings were 8,183 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caveness Michelle H

(Last) (First) (Middle)

200 SOUTH WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chf. Mfg. Ofc.

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		1,937(1)	A	$0	8,183	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Determination of the number of performance shares earned for the three-year (2023- 2025) performance period.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Michelle H. Caveness	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EMN executive Michelle Caveness report?

Michelle H. Caveness reported receiving a stock award of 1,937 Eastman Chemical common shares. The grant was recorded at $0 per share and reflects compensation earned based on performance over a defined 2023–2025 period, rather than an open-market trade.

How many EMN shares does Michelle Caveness own after this Form 4?

After the reported grant, Michelle H. Caveness directly owns 8,183 shares of Eastman Chemical common stock. This total includes the 1,937-share award tied to performance results over the 2023–2025 period that was credited on February 11, 2026.

Was the EMN insider transaction a stock purchase or a grant?

The transaction was a grant, not a market purchase. Michelle H. Caveness acquired 1,937 Eastman Chemical common shares at $0 per share as a performance-based award, reflecting the number of performance shares earned for the 2023–2025 performance period.

What performance period is linked to Michelle Caveness’s EMN share award?

The share award is tied to performance over the three-year 2023–2025 period. The filing explains that the 1,937 shares represent the determination of performance shares earned for that timeframe, which were then granted as common stock on February 11, 2026.

What role does Michelle Caveness hold at Eastman Chemical (EMN)?

Michelle H. Caveness serves as Eastman Chemical’s Senior Vice President and Chief Manufacturing Officer. Her Form 4 filing reports a grant of 1,937 common shares as compensation, increasing her directly held ownership stake to 8,183 shares in total.